BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

HENRY MEDS — Lobbying — Receipts Report

LD-2 disclosure · 4th Quarter - Report

HENRY MEDS

via RUBICON ADVISORS, LLC

4th Quarter (Oct 1 - Dec 31) · 2025Posted Jan 18, 2026Filing document ↗LDA record ↗

Income$60Kfee reported

Client

Name: HENRY MEDS
Description: Pharmaceutical manufacturer
Location: Delaware · United States of America

Registrant

Firm: RUBICON ADVISORS, LLC
Description: Lobbying firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Pharmacy
Telehealth Compounding, Regulatory Intelligence
LobbyistsWILLIAM BURKE
Covered position (WILLIAM BURKE): Lobbyist
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.